Singapore
The firm focuses on India, Australia, and SE Asia.
1
FTSE Russell names Hoa Phat, Vingroup, FPT for Vietnam's emerging-market upgrade
2
Alibaba launches $10b HK share placement to fund AI spending
3
Rising Tide leads $19.5m funding in Battery Smart and other India deals
4
Editor’s Take: The Week That Was—Aug 17-22
5
Chandra Asri to buy Cycle & Carriage's Singapore, Malaysia biz for $208m
More Stories
Beyond the Buyout: China’s USD fundraising is back, but it has a catch
Chandra Asri to buy Cycle & Carriage’s Singapore, Malaysia biz for $208m
When will the music stop for China’s AI listing boom?
Five things you didn’t know about Chinese humanoid robot maker Unitree
Rest of Asia
Asian target could bring bigger presence or more clients, William Huffman says.
The firm is in discussions to hire a Partner in Singapore.
Greater China
This gives it an edge over traditional Western pharmaceutical giants.
The firm also sees opportunities in the mid-market space in Japan.
Infrastructure as an asset class has typically been generating stable, long-term returns.
The firm’s private wealth AUM hit $17.8 billion by March 31, 2026.
It is also on track to close its second PE Fund.
The fintech sees stablecoins becoming an increasingly visible part of global money movement.
President and COO Jonathan Gray says the firm aims to capture entire AI ecosystem.
